HT
TAK icon

HAP Trading’s Takeda Pharmaceutical TAK Stock Holding History

HAP Trading’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-263,679
Closed -$4.08M – 1182
2023
Q3 		$4.08M Buy
263,679
+222,700
+543% +$3.45M 0.65% 27
2023
Q2 		$644K Buy
+40,979
New +$671K 0.11% 165
2022
Q3 		– Sell
-244,276
Closed -$3.4M – 2063
2022
Q2 		$3.43M Buy
+244,276
New +$3.49M 0.17% 115
2022
Q1 		– Sell
-788,811
Closed -$11.6M – 2742
2021
Q4 		$10.8M Buy
788,811
+670,365
+566% +$9.4M 0.29% 53
2021
Q3 		$1.94M Buy
118,446
+27,702
+31% +$465K 0.06% 289
2021
Q2 		$1.53M Buy
+90,744
New +$1.54M 0.05% 343

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

HAP Trading's TAK Position: Q4 2023 in Review

HAP Trading sold out of Takeda Pharmaceutical (TAK) in Q4 2023, closing a stake of 263,679 shares — an estimated $4.08M sold.

HAP Trading first reported a position in TAK in Q2 2021 and held it in 6 quarters. The position peaked at $10.8M in Q4 2021. 306 funds tracked by Wall St. Rank hold TAK as of Q4 2023.

  • HAP Trading reported no remaining Takeda Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • HAP Trading sold 263,679 Takeda Pharmaceutical shares in Q4 2023, an estimated $4.08M.
  • HAP Trading first reported a position in Takeda Pharmaceutical in Q2 2021 and held it in 6 quarters.
  • HAP Trading's Takeda Pharmaceutical position peaked at $10.8M in Q4 2021.
  • 306 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2023.

Based on HAP Trading's 13F filing for Q4 2023, filed 14 Feb 2024.